$MPAD
MICROPAC INDUSTRIES INC Stock $mpad

$mpad Overview Financials Valuation SEC Filings Company Website

2024 Q2 Form 10-Q Financial Statement

#000121465924006491 Filed on April 10, 2024

Income Statement

Concept	2024 Q2	2024 Q1	2023 Q1
Revenue	$8.063M	$6.118M	$6.190M
YoY Change	8.33%	-1.16%	2.04%
Cost Of Revenue	$4.972M	$3.504M	$3.939M
YoY Change	8.49%	-11.04%	20.24%
Gross Profit	$3.091M	$2.614M	$2.251M
YoY Change	8.08%	16.13%	-19.32%
Gross Profit Margin	38.34%	42.73%	36.37%
Selling, General & Admin	$2.219M	$1.912M	$1.806M
YoY Change	10.4%	5.87%	2.15%
% of Gross Profit	71.79%	73.14%	80.23%
Research & Development	$549.0K	$494.0K	$652.0K
YoY Change	-12.16%	-24.23%	40.52%
% of Gross Profit	17.76%	18.9%	28.96%
Depreciation & Amortization	$266.0K	$265.0K	$103.0K
YoY Change	-2.56%	157.28%	5.1%
% of Gross Profit	8.61%	10.14%	4.58%
Operating Expenses	$2.768M	$2.406M	$2.458M
YoY Change	5.05%	-2.12%	10.13%
Operating Profit	$323.0K	$208.0K	-$207.0K
YoY Change	43.56%	-200.48%	-137.1%
Interest Expense	$10.00K	-$142.0K
YoY Change	233.33%
% of Operating Profit	3.1%	-68.27%
Other Income/Expense, Net	$706.0K	$147.0K	$139.0K
YoY Change	2039.39%	5.76%	13800.0%
Pretax Income	$1.019M	$213.0K	-$68.00K
YoY Change	294.96%	-413.24%	-112.16%
Income Tax	$173.0K	$36.00K	-$12.00K
% Of Pretax Income	16.98%	16.9%
Net Earnings	$846.0K	$177.0K	-$56.00K
YoY Change	295.33%	-416.07%	-112.07%
Net Earnings / Revenue	10.49%	2.89%	-0.9%
Basic Earnings Per Share	$0.33	$0.07	-$0.02
Diluted Earnings Per Share	$0.32	$0.07	-$0.02
COMMON SHARES
Basic Shares Outstanding	2.578M shares	2.578M shares	2.578M shares
Diluted Shares Outstanding	2.610M shares	2.610M shares	2.578M shares

Balance Sheet

Concept	2024 Q2	2024 Q1	2023 Q1
SHORT-TERM ASSETS
Cash & Short-Term Investments	$11.02M	$9.869M	$13.24M
YoY Change	-5.52%	-25.48%	-16.72%
Cash & Equivalents	$11.02M	$9.869M	$13.24M
Short-Term Investments
Other Short-Term Assets	$366.0K	$280.0K	$594.0K
YoY Change	-0.27%	-52.86%	112.14%
Inventory	$13.21M	$14.50M	$11.34M
Prepaid Expenses
Receivables	$5.182M	$5.174M	$3.532M
Other Receivables	$121.0K	$120.0K	$920.0K
Total Short-Term Assets	$29.90M	$29.94M	$29.63M
YoY Change	3.04%	1.06%	1.08%
LONG-TERM ASSETS
Property, Plant & Equipment	$23.64M	$23.87M	$22.76M
YoY Change	-3.42%	4.87%	44.03%
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments
YoY Change
Other Assets	$475.0K	$475.0K	$86.00K
YoY Change	452.33%	452.33%
Total Long-Term Assets	$24.12M	$24.35M	$22.85M
YoY Change	-1.82%	6.56%	44.57%
TOTAL ASSETS
Total Short-Term Assets	$29.90M	$29.94M	$29.63M
Total Long-Term Assets	$24.12M	$24.35M	$22.85M
Total Assets	$54.01M	$54.29M	$52.48M
YoY Change	0.81%	3.45%	16.32%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable	$696.0K	$1.900M	$1.469M
YoY Change	-16.95%	29.34%	-12.82%
Accrued Expenses	$1.336M	$1.011M	$998.0K
YoY Change	9.42%	1.3%	1.53%
Deferred Revenue
YoY Change
Short-Term Debt	$439.0K	$0.00	$225.0K
YoY Change		-100.0%
Long-Term Debt Due	$439.0K	$436.0K	$225.0K
YoY Change	55.67%	93.78%
Total Short-Term Liabilities	$2.796M	$3.853M	$3.363M
YoY Change	-10.1%	14.57%	-20.78%
LONG-TERM LIABILITIES
Long-Term Debt	$15.11M	$15.21M	$14.63M
YoY Change	-3.98%	3.95%	74.57%
Other Long-Term Liabilities
YoY Change
Total Long-Term Liabilities	$15.11M	$15.21M	$14.63M
YoY Change	-3.98%	3.95%	74.57%
TOTAL LIABILITIES
Total Short-Term Liabilities	$2.796M	$3.853M	$3.363M
Total Long-Term Liabilities	$15.11M	$15.21M	$14.63M
Total Liabilities	$17.90M	$19.07M	$18.00M
YoY Change	-4.99%	5.93%	42.34%
SHAREHOLDERS EQUITY
Retained Earnings	$35.99M	$35.15M	$34.54M
YoY Change	3.57%	1.76%
Common Stock	$308.0K	$308.0K	$308.0K
YoY Change	0.0%	0.0%
Preferred Stock
YoY Change
Treasury Stock (at cost)	$1.250M	$1.250M	$1.250M
YoY Change	0.0%	0.0%
Treasury Stock Shares
Shareholders Equity	$36.11M	$35.23M	$34.48M
YoY Change
Total Liabilities & Shareholders Equity	$54.01M	$54.29M	$52.48M
YoY Change	0.81%	3.45%	16.32%

Cashflow Statement

Concept	2024 Q2	2024 Q1	2023 Q1
OPERATING ACTIVITIES
Net Income	$846.0K	$177.0K	-$56.00K
YoY Change	295.33%	-416.07%	-112.07%
Depreciation, Depletion And Amortization	$266.0K	$265.0K	$103.0K
YoY Change	-2.56%	157.28%	5.1%
Cash From Operating Activities	$583.0K	-$29.00K	-$1.493M
YoY Change	-169.65%	-98.06%	-226.96%
INVESTING ACTIVITIES
Capital Expenditures	$33.00K	$40.00K	$480.0K
YoY Change	-98.26%	-91.67%	-109.09%
Acquisitions
YoY Change
Other Investing Activities	$706.0K
YoY Change
Cash From Investing Activities	$673.0K	-$40.00K	-$480.0K
YoY Change	-135.4%	-91.67%	-90.91%
FINANCING ACTIVITIES
Cash Dividend Paid		$258.0K	$258.0K
YoY Change		0.0%	0.0%
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net		$103.0K
YoY Change
Cash From Financing Activities	-108.0K	-361.0K	-$158.0K
YoY Change	-109.35%	128.48%	-103.32%
NET CHANGE
Cash From Operating Activities	583.0K	-29.00K	-$1.493M
Cash From Investing Activities	673.0K	-40.00K	-$480.0K
Cash From Financing Activities	-108.0K	-361.0K	-$158.0K
Net Change In Cash	1.148M	-430.0K	-$2.131M
YoY Change	-172.52%	-79.82%	-427.34%
FREE CASH FLOW
Cash From Operating Activities	$583.0K	-$29.00K	-$1.493M
Capital Expenditures	$33.00K	$40.00K	$480.0K
Free Cash Flow	$550.0K	-$69.00K	-$1.973M
YoY Change	-120.09%	-96.5%	-130.56%

Facts In Submission

Frame	Concept Type	Concept / XBRL Key	Value	Unit
CY2023Q1	us-gaap	Interest Expense InterestExpense		usd
CY2023Q1	us-gaap	Share Based Compensation ShareBasedCompensation		usd
CY2024Q1	us-gaap	Operating Lease Right Of Use Asset Amortization Expense OperatingLeaseRightOfUseAssetAmortizationExpense		usd
CY2024Q1	us-gaap	Increase Decrease In Operating Lease Liability IncreaseDecreaseInOperatingLeaseLiability		usd
CY2024Q1	us-gaap	Proceeds From Issuance Of Long Term Debt ProceedsFromIssuanceOfLongTermDebt		usd
CY2023Q1	us-gaap	Repayments Of Long Term Debt RepaymentsOfLongTermDebt		usd
CY2023Q1	MPAD	Restricted Stock Units RestrictedStockUnits		shares
CY2023Q1	us-gaap	Share Based Compensation ShareBasedCompensation		usd
CY2024Q1	us-gaap	Allowance For Doubtful Accounts Receivable Current AllowanceForDoubtfulAccountsReceivableCurrent	0	usd
CY2024Q1	us-gaap	Other Receivables OtherReceivables	120000	usd
CY2023Q4	us-gaap	Other Receivables OtherReceivables	139000	usd
CY2024Q1	us-gaap	Contract With Customer Asset Net Current ContractWithCustomerAssetNetCurrent	501000	usd
CY2023Q4	us-gaap	Contract With Customer Asset Net Current ContractWithCustomerAssetNetCurrent	307000	usd
CY2024Q1	us-gaap	Inventory Raw Materials And Supplies InventoryRawMaterialsAndSupplies	8607000	usd
CY2023Q4	us-gaap	Inventory Raw Materials And Supplies InventoryRawMaterialsAndSupplies	7367000	usd
CY2024Q1	us-gaap	Inventory Work In Process And Raw Materials InventoryWorkInProcessAndRawMaterials	5893000	usd
CY2023Q4	us-gaap	Inventory Work In Process And Raw Materials InventoryWorkInProcessAndRawMaterials	4113000	usd
CY2024Q1	us-gaap	Inventory Net InventoryNet	14500000	usd
CY2023Q4	us-gaap	Inventory Net InventoryNet	11480000	usd
CY2024Q1	us-gaap	Prepaid Expense And Other Assets Current PrepaidExpenseAndOtherAssetsCurrent	280000	usd
CY2023Q4	us-gaap	Prepaid Expense And Other Assets Current PrepaidExpenseAndOtherAssetsCurrent	487000	usd
CY2024Q1	us-gaap	Assets Current AssetsCurrent	29943000	usd
CY2023Q4	us-gaap	Assets Current AssetsCurrent	30733000	usd
CY2024Q1	us-gaap	Land Land	1518000	usd
CY2023Q4	us-gaap	Land Land	1518000	usd
CY2024Q1	us-gaap	Buildings And Improvements Gross BuildingsAndImprovementsGross	21013000	usd
CY2023Q4	us-gaap	Buildings And Improvements Gross BuildingsAndImprovementsGross	21013000	usd
CY2024Q1	us-gaap	Inventory Buildings And Improvements InventoryBuildingsAndImprovements	1126000	usd
CY2023Q4	us-gaap	Inventory Buildings And Improvements InventoryBuildingsAndImprovements	1126000	usd
CY2024Q1	us-gaap	Furniture And Fixtures Gross FurnitureAndFixturesGross	2068000	usd
CY2023Q4	us-gaap	Furniture And Fixtures Gross FurnitureAndFixturesGross	2068000	usd
CY2024Q1	us-gaap	Flight Equipment Net FlightEquipmentNet	206000	usd
CY2023Q4	us-gaap	Flight Equipment Net FlightEquipmentNet	181000	usd
CY2024Q1	us-gaap	Machinery And Equipment Gross MachineryAndEquipmentGross	10189000	usd
CY2023Q4	us-gaap	Machinery And Equipment Gross MachineryAndEquipmentGross	10175000	usd
CY2024Q1	us-gaap	Property Plant And Equipment Gross PropertyPlantAndEquipmentGross	36120000	usd
CY2023Q4	us-gaap	Property Plant And Equipment Gross PropertyPlantAndEquipmentGross	36081000	usd
CY2024Q1	us-gaap	Accumulated Depreciation Depletion And Amortization Property Plant And Equipment AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment	12247000	usd
CY2023Q4	us-gaap	Accumulated Depreciation Depletion And Amortization Property Plant And Equipment AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment	11982000	usd
CY2024Q1	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	23873000	usd
CY2023Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	24099000	usd
CY2024Q1	us-gaap	Deferred Income Tax Assets Net DeferredIncomeTaxAssetsNet	475000	usd
CY2023Q4	us-gaap	Deferred Income Tax Assets Net DeferredIncomeTaxAssetsNet	475000	usd
CY2024Q1	us-gaap	Assets Assets	54291000	usd
CY2023Q4	us-gaap	Assets Assets	55307000	usd
CY2024Q1	us-gaap	Accounts Payable Current AccountsPayableCurrent	1900000	usd
CY2023Q4	us-gaap	Accounts Payable Current AccountsPayableCurrent	1491000	usd
CY2024Q1	us-gaap	Employee Related Liabilities Current EmployeeRelatedLiabilitiesCurrent	861000	usd
CY2023Q4	us-gaap	Employee Related Liabilities Current EmployeeRelatedLiabilitiesCurrent	958000	usd
CY2024Q1	us-gaap	Deferred Revenue DeferredRevenue	455000	usd
CY2023Q4	us-gaap	Deferred Revenue DeferredRevenue	618000	usd
CY2024Q1	MPAD	Property Taxes PropertyTaxes	125000	usd
CY2023Q4	MPAD	Property Taxes PropertyTaxes	746000	usd
CY2024Q1	us-gaap	Taxes Payable Current TaxesPayableCurrent	51000	usd
CY2023Q4	us-gaap	Taxes Payable Current TaxesPayableCurrent	444000	usd
CY2024Q1	us-gaap	Short Term Borrowings ShortTermBorrowings	436000	usd
CY2023Q4	us-gaap	Short Term Borrowings ShortTermBorrowings	432000	usd
CY2024Q1	us-gaap	Other Accrued Liabilities Current OtherAccruedLiabilitiesCurrent	25000	usd
CY2023Q4	us-gaap	Other Accrued Liabilities Current OtherAccruedLiabilitiesCurrent	34000	usd
CY2024Q1	us-gaap	Liabilities Current LiabilitiesCurrent	3853000	usd
CY2023Q4	us-gaap	Liabilities Current LiabilitiesCurrent	4723000	usd
CY2024Q1	us-gaap	Long Term Debt Noncurrent LongTermDebtNoncurrent	15212000	usd
CY2023Q4	us-gaap	Long Term Debt Noncurrent LongTermDebtNoncurrent	15316000	usd
CY2024Q1	us-gaap	Liabilities Liabilities	19065000	usd
CY2023Q4	us-gaap	Liabilities Liabilities	20039000	usd
CY2024Q1	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.10
CY2024Q1	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	10000000	shares
CY2024Q1	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	3078315	shares
CY2024Q1	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	2578315	shares
CY2024Q1	us-gaap	Common Stock Value CommonStockValue	308000	usd
CY2023Q4	us-gaap	Common Stock Value CommonStockValue	308000	usd
CY2024Q1	us-gaap	Additional Paid In Capital AdditionalPaidInCapital	1022000	usd
CY2023Q4	us-gaap	Additional Paid In Capital AdditionalPaidInCapital	983000	usd
CY2024Q1	MPAD	Treasury Stocks Shares TreasuryStocksShares	500000	shares
CY2024Q1	us-gaap	Treasury Stock Value TreasuryStockValue	1250000	usd
CY2023Q4	us-gaap	Treasury Stock Value TreasuryStockValue	1250000	usd
CY2024Q1	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	35146000	usd
CY2023Q4	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	35227000	usd
CY2024Q1	us-gaap	Stockholders Equity StockholdersEquity	35226000	usd
CY2023Q4	us-gaap	Stockholders Equity StockholdersEquity	35268000	usd
CY2024Q1	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	54291000	usd
CY2023Q4	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	55307000	usd
CY2024Q1	us-gaap	Revenues Revenues	6118000	usd
CY2023Q1	us-gaap	Revenues Revenues	6190000	usd
CY2024Q1	us-gaap	Cost Of Revenue CostOfRevenue	3504000	usd
CY2023Q1	us-gaap	Cost Of Revenue CostOfRevenue	3939000	usd
CY2024Q1	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	494000	usd
CY2023Q1	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	652000	usd
CY2024Q1	us-gaap	Selling General And Administrative Expense SellingGeneralAndAdministrativeExpense	1912000	usd
CY2023Q1	us-gaap	Selling General And Administrative Expense SellingGeneralAndAdministrativeExpense	1806000	usd
CY2024Q1	us-gaap	Costs And Expenses CostsAndExpenses	5910000	usd
CY2023Q1	us-gaap	Costs And Expenses CostsAndExpenses	6397000	usd
CY2024Q1	us-gaap	Operating Income Loss OperatingIncomeLoss	208000	usd
CY2023Q1	us-gaap	Operating Income Loss OperatingIncomeLoss	-207000	usd
CY2024Q1	us-gaap	Interest Expense InterestExpense	142000	usd
CY2024Q1	us-gaap	Other Income OtherIncome	147000	usd
CY2023Q1	us-gaap	Other Income OtherIncome	139000	usd
CY2024Q1	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	213000	usd
CY2023Q1	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-68000	usd
CY2024Q1	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	36000	usd
CY2023Q1	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	-12000	usd
CY2024Q1	us-gaap	Net Income Loss NetIncomeLoss	177000	usd
CY2023Q1	us-gaap	Net Income Loss NetIncomeLoss	-56000	usd
CY2024Q1	us-gaap	Common Stock Dividends Per Share Cash Paid CommonStockDividendsPerShareCashPaid	0.10
CY2023Q1	us-gaap	Common Stock Dividends Per Share Cash Paid CommonStockDividendsPerShareCashPaid	0.10
CY2024Q1	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	0.07
CY2023Q1	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.02
CY2024Q1	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	2578315	shares
CY2023Q1	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	2578315	shares
CY2024Q1	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	0.07
CY2023Q1	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.02
CY2024Q1	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	2609509	shares
CY2023Q1	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	2578315	shares
CY2024Q1	us-gaap	Depreciation Depreciation	265000	usd
CY2023Q1	us-gaap	Depreciation Depreciation	103000	usd
CY2024Q1	us-gaap	Share Based Compensation ShareBasedCompensation	39000	usd
CY2024Q1	us-gaap	Amortization Of Financing Costs AmortizationOfFinancingCosts	3000	usd
CY2023Q1	us-gaap	Amortization Of Financing Costs AmortizationOfFinancingCosts	28000	usd
CY2023Q1	us-gaap	Operating Lease Right Of Use Asset Amortization Expense OperatingLeaseRightOfUseAssetAmortizationExpense	14000	usd
CY2024Q1	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	-3368000	usd
CY2023Q1	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	-834000	usd
CY2024Q1	us-gaap	Increase Decrease In Contract With Customer Asset IncreaseDecreaseInContractWithCustomerAsset	194000	usd
CY2023Q1	us-gaap	Increase Decrease In Contract With Customer Asset IncreaseDecreaseInContractWithCustomerAsset	314000	usd
CY2024Q1	us-gaap	Increase Decrease In Inventories IncreaseDecreaseInInventories	3020000	usd
CY2023Q1	us-gaap	Increase Decrease In Inventories IncreaseDecreaseInInventories	1051000	usd
CY2024Q1	us-gaap	Increase Decrease In Prepaid Deferred Expense And Other Assets IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets	-207000	usd
CY2023Q1	us-gaap	Increase Decrease In Prepaid Deferred Expense And Other Assets IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets	29000	usd
CY2024Q1	us-gaap	Increase Decrease In Deferred Revenue IncreaseDecreaseInDeferredRevenue	-162000	usd
CY2023Q1	us-gaap	Increase Decrease In Deferred Revenue IncreaseDecreaseInDeferredRevenue	-546000	usd
CY2024Q1	us-gaap	Increase Decrease In Accounts Payable IncreaseDecreaseInAccountsPayable	408000	usd
CY2023Q1	us-gaap	Increase Decrease In Accounts Payable IncreaseDecreaseInAccountsPayable	372000	usd
CY2024Q1	MPAD	Accrued Compensation AccruedCompensation	96000	usd
CY2023Q1	MPAD	Accrued Compensation AccruedCompensation	244000	usd
CY2024Q1	us-gaap	Increase Decrease In Accrued Income Taxes Payable IncreaseDecreaseInAccruedIncomeTaxesPayable	-394000	usd
CY2023Q1	us-gaap	Increase Decrease In Accrued Income Taxes Payable IncreaseDecreaseInAccruedIncomeTaxesPayable	-124000	usd
CY2023Q1	us-gaap	Increase Decrease In Operating Lease Liability IncreaseDecreaseInOperatingLeaseLiability	-14000	usd
CY2024Q1	us-gaap	Increase Decrease In Accrued Liabilities IncreaseDecreaseInAccruedLiabilities	-625000	usd
CY2023Q1	us-gaap	Increase Decrease In Accrued Liabilities IncreaseDecreaseInAccruedLiabilities	-131000	usd
CY2024Q1	us-gaap	Increase Decrease In Other Accrued Liabilities IncreaseDecreaseInOtherAccruedLiabilities	-5000	usd
CY2023Q1	us-gaap	Increase Decrease In Other Accrued Liabilities IncreaseDecreaseInOtherAccruedLiabilities	-335000	usd
CY2024Q1	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-29000	usd
CY2023Q1	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-1493000	usd
CY2024Q1	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	40000	usd
CY2023Q1	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	480000	usd
CY2024Q1	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-40000	usd
CY2023Q1	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-480000	usd
CY2024Q1	us-gaap	Payments Of Dividends PaymentsOfDividends	258000	usd
CY2023Q1	us-gaap	Payments Of Dividends PaymentsOfDividends	258000	usd
CY2023Q1	us-gaap	Proceeds From Issuance Of Long Term Debt ProceedsFromIssuanceOfLongTermDebt	100000	usd
CY2024Q1	us-gaap	Repayments Of Long Term Debt RepaymentsOfLongTermDebt	103000	usd
CY2024Q1	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	-361000	usd
CY2023Q1	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	-158000	usd
CY2024Q1	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect	-430000	usd
CY2023Q1	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect	-2131000	usd
CY2023Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	10299000	usd
CY2022Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	15375000	usd
CY2024Q1	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	9869000	usd
CY2023Q1	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	13244000	usd
CY2024Q1	us-gaap	Income Taxes Paid Net IncomeTaxesPaidNet	430000	usd
CY2023Q1	us-gaap	Income Taxes Paid Net IncomeTaxesPaidNet	118000	usd
CY2024Q1	us-gaap	Interest Paid Net InterestPaidNet	138000	usd
CY2023Q1	us-gaap	Interest Paid Net InterestPaidNet	130000	usd
CY2024Q1	MPAD	Accrued Additions Property Plant Equipment AccruedAdditionsPropertyPlantEquipment	22000	usd
CY2023Q1	MPAD	Accrued Additions Property Plant Equipment AccruedAdditionsPropertyPlantEquipment	75000	usd
CY2022Q4	us-gaap	Stockholders Equity StockholdersEquity	34796000	usd
CY2023Q1	us-gaap	Dividends Dividends	258000	usd
CY2023Q1	us-gaap	Profit Loss ProfitLoss	-56000	usd
CY2023Q1	us-gaap	Stockholders Equity StockholdersEquity	34482000	usd
CY2023Q4	us-gaap	Stockholders Equity StockholdersEquity	35268000	usd
CY2024Q1	us-gaap	Adjustments Related To Tax Withholding For Share Based Compensation AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation	39000	usd
CY2024Q1	us-gaap	Dividends Dividends	258000	usd
CY2024Q1	us-gaap	Profit Loss ProfitLoss	177000	usd
CY2024Q1	us-gaap	Stockholders Equity StockholdersEquity	35226000	usd
CY2024Q1	us-gaap	Revenues Revenues	6118000	usd
CY2023Q1	us-gaap	Revenues Revenues	6190000	usd
CY2024Q1	us-gaap	Revenues Revenues	6118000	usd
CY2023Q1	us-gaap	Revenues Revenues	6190000	usd
CY2024Q1	MPAD	Domestic Direct DomesticDirect	4001000	usd
CY2024Q1	MPAD	Domestic Distrbution DomesticDistrbution	1748000	usd
CY2024Q1	MPAD	International Distribution InternationalDistribution	369000	usd
CY2024Q1	us-gaap	Revenues Revenues	6118000	usd
CY2023Q1	MPAD	Domestic Direct DomesticDirect	3618000	usd
CY2023Q1	MPAD	Domestic Distrbution DomesticDistrbution	2296000	usd
CY2023Q1	MPAD	International Distribution InternationalDistribution	276000	usd
CY2023Q1	us-gaap	Revenues Revenues	6190000	usd
CY2024Q1	us-gaap	Receivables Net Current ReceivablesNetCurrent	4673000	usd
CY2023Q4	us-gaap	Receivables Net Current ReceivablesNetCurrent	8021000	usd
CY2022Q4	us-gaap	Receivables Net Current ReceivablesNetCurrent	3644000	usd
CY2024Q1	us-gaap	Contract With Customer Asset Net Current ContractWithCustomerAssetNetCurrent	501000	usd
CY2023Q4	us-gaap	Contract With Customer Asset Net Current ContractWithCustomerAssetNetCurrent	307000	usd
CY2022Q4	us-gaap	Contract With Customer Asset Net Current ContractWithCustomerAssetNetCurrent	408000	usd
CY2024Q1	us-gaap	Deferred Revenue DeferredRevenue	455000	usd
CY2023Q4	us-gaap	Deferred Revenue DeferredRevenue	618000	usd
CY2022Q4	us-gaap	Deferred Revenue DeferredRevenue	1192000	usd
CY2024Q1	MPAD	Deferred Revenue Recognized DeferredRevenueRecognized	162000	usd
CY2020Q1	us-gaap	Lessee Finance Lease Remaining Lease Term LesseeFinanceLeaseRemainingLeaseTerm	P3Y
CY2020Q1	us-gaap	Operating Lease Liability OperatingLeaseLiability	165000	usd
CY2020Q1	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	165000	usd
CY2024Q1	us-gaap	Operating Lease Expense OperatingLeaseExpense	14000	usd
CY2024Q1	us-gaap	Liability For Uncertain Tax Positions Current LiabilityForUncertainTaxPositionsCurrent	0	usd
CY2023Q4	us-gaap	Liability For Uncertain Tax Positions Current LiabilityForUncertainTaxPositionsCurrent	0	usd
CY2024Q1	us-gaap	Use Of Estimates UseOfEstimates	<p id="xdx_84C_eus-gaap--UseOfEstimates_zAlfCLbWFfv5" style="font: italic bold 10pt Times New Roman; margin: 0pt 0; text-align: justify"><span id="xdx_863_zFUwx1ZoYcBh">Use of Estimates</span></p> <p style="font: 10pt Times New Roman; margin: 0pt 0"> </p> <p style="font: 10pt Times New Roman; margin: 0pt 0; text-align: justify">The preparation of financial statements in conformity with GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of revenues and expenses during the reporting period. Actual results could differ from those estimates.</p> <p style="font: 10pt Times New Roman; margin: 0pt 0"> </p>
CY2024Q1	MPAD	Fair Value Financial Assets Liabilities Recurring Basis FairValueFinancialAssetsLiabilitiesRecurringBasis	0	usd
CY2023Q4	MPAD	Fair Value Financial Assets Liabilities Recurring Basis FairValueFinancialAssetsLiabilitiesRecurringBasis	0	usd
CY2024Q1	MPAD	Fair Value Non Financial Assets Non Recurring Basis FairValueNonFinancialAssetsNonRecurringBasis	0	usd
CY2023Q4	MPAD	Fair Value Non Financial Assets Non Recurring Basis FairValueNonFinancialAssetsNonRecurringBasis	0	usd
CY2024Q1	us-gaap	Notes Payable NotesPayable	15780000	usd
CY2024Q1	us-gaap	Unamortized Debt Issuance Expense UnamortizedDebtIssuanceExpense	132000	usd
CY2024Q1	MPAD	Net Debt NetDebt	15648000	usd
CY2024Q1	us-gaap	Debt Current DebtCurrent	436000	usd
CY2024Q1	us-gaap	Long Term Debt Noncurrent LongTermDebtNoncurrent	15212000	usd
CY2024Q1	us-gaap	Long Term Debt Maturities Repayments Of Principal In Next Twelve Months LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths	326000	usd
CY2024Q1	us-gaap	Long Term Debt Maturities Repayments Of Principal In Year Two LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo	447000	usd
CY2024Q1	us-gaap	Long Term Debt Maturities Repayments Of Principal In Year Three LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree	463000	usd
CY2024Q1	us-gaap	Long Term Debt Maturities Repayments Of Principal In Year Four LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour	479000	usd
CY2024Q1	us-gaap	Long Term Debt Maturities Repayments Of Principal In Year Five LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFive	495000	usd
CY2024Q1	us-gaap	Long Term Debt Maturities Repayments Of Principal After Year Five LongTermDebtMaturitiesRepaymentsOfPrincipalAfterYearFive	13572000	usd
CY2024Q1	us-gaap	Long Term Debt LongTermDebt	15780000	usd
CY2024Q1	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	2578315	shares
CY2023Q1	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	2578315	shares
CY2024Q1	MPAD	Restricted Stock Units RestrictedStockUnits	31194	shares
CY2024Q1	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	2609509	shares
CY2023Q1	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	2578315	shares
CY2024Q1	us-gaap	Dividends Payable Date Declared Day Month And Year DividendsPayableDateDeclaredDayMonthAndYear	2023-12-05
CY2024Q1	us-gaap	Common Stock Dividends Per Share Cash Paid CommonStockDividendsPerShareCashPaid	0.10
CY2024Q1	us-gaap	Dividends Payable Date Of Record Day Month And Year DividendsPayableDateOfRecordDayMonthAndYear	2024-01-10
CY2024Q1	us-gaap	Dividend Payable Date To Be Paid Day Month And Year DividendPayableDateToBePaidDayMonthAndYear	2024-02-09
CY2023Q1	us-gaap	Dividends Payable Date Declared Day Month And Year DividendsPayableDateDeclaredDayMonthAndYear	2022-12-07
CY2023Q1	us-gaap	Common Stock Dividends Per Share Cash Paid CommonStockDividendsPerShareCashPaid	0.10
CY2023Q1	us-gaap	Dividends Payable Date Of Record Day Month And Year DividendsPayableDateOfRecordDayMonthAndYear	2023-01-11
CY2023Q1	us-gaap	Dividend Payable Date To Be Paid Day Month And Year DividendPayableDateToBePaidDayMonthAndYear	2023-02-10
CY2024Q1	us-gaap	Share Based Compensation ShareBasedCompensation	39000	usd
CY2024Q1	MPAD	Stockbased Unvested Compensation Expense For Second Year StockbasedUnvestedCompensationExpenseForSecondYear	156000	usd
CY2024Q1	MPAD	Stockbased Unvested Compensation Expense For Third Year StockbasedUnvestedCompensationExpenseForThirdYear	156000	usd
CY2024Q1	MPAD	Stockbased Unvested Compensation Expense StockbasedUnvestedCompensationExpense	312000	usd

Files In Submission

Name	View Source	Status
0001214659-24-006491-index-headers.html	Edgar Link	pending
0001214659-24-006491-index.html	Edgar Link	pending
0001214659-24-006491.txt	Edgar Link	pending
0001214659-24-006491-xbrl.zip	Edgar Link	pending
ex31_1.htm	Edgar Link	pending
ex31_2.htm	Edgar Link	pending
ex32_1.htm	Edgar Link	pending
ex32_2.htm	Edgar Link	pending
Financial_Report.xlsx	Edgar Link	pending
MetaLinks.json	Edgar Link	pending
mp4924010q.htm	Edgar Link	pending
mpad-20240224.xsd	Edgar Link	pending
R1.htm	Edgar Link	pending
R10.htm	Edgar Link	pending
R11.htm	Edgar Link	pending
R12.htm	Edgar Link	pending
R13.htm	Edgar Link	pending
R14.htm	Edgar Link	pending
R15.htm	Edgar Link	pending
R16.htm	Edgar Link	pending
R17.htm	Edgar Link	pending
R18.htm	Edgar Link	pending
R19.htm	Edgar Link	pending
R2.htm	Edgar Link	pending
FilingSummary.xml	Edgar Link	unprocessable
mpad-20240224_cal.xml	Edgar Link	unprocessable
mpad-20240224_def.xml	Edgar Link	unprocessable
mpad-20240224_lab.xml	Edgar Link	unprocessable
mpad-20240224_pre.xml	Edgar Link	unprocessable
mp4924010q_htm.xml	Edgar Link	completed
R20.htm	Edgar Link	pending
R21.htm	Edgar Link	pending
R22.htm	Edgar Link	pending
R23.htm	Edgar Link	pending
R24.htm	Edgar Link	pending
R25.htm	Edgar Link	pending
R26.htm	Edgar Link	pending
R27.htm	Edgar Link	pending
R28.htm	Edgar Link	pending
R29.htm	Edgar Link	pending
R3.htm	Edgar Link	pending
R30.htm	Edgar Link	pending
R31.htm	Edgar Link	pending
R32.htm	Edgar Link	pending
R33.htm	Edgar Link	pending
R34.htm	Edgar Link	pending
R35.htm	Edgar Link	pending
R4.htm	Edgar Link	pending
R5.htm	Edgar Link	pending
R6.htm	Edgar Link	pending
R7.htm	Edgar Link	pending
R8.htm	Edgar Link	pending
R9.htm	Edgar Link	pending
report.css	Edgar Link	pending
Show.js	Edgar Link	pending

Create your account

Find Stocks Worth Researching

Deeply Understand Businesses

Value Businesses Intelligently

$MPAD
MICROPAC INDUSTRIES INC Stock $mpad

2024 Q2 Form 10-Q Financial Statement

#000121465924006491 Filed on April 10, 2024

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$MPAD MICROPAC INDUSTRIES INC Stock $mpad

2024 Q2 Form 10-Q Financial Statement

#000121465924006491 Filed on April 10, 2024

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$MPAD
MICROPAC INDUSTRIES INC Stock $mpad